British health regulators who authorized Pfizer’s Covid-19 vaccine on Wednesday did not scrutinize the trial data as carefully as the US Food and Drug Administration is doing in its review, Dr. Anthony Fauci, the director of the National Institute of Allergy and Infectious Diseases, claimed.
“The way the FDA is, our FDA is doing it, is the correct way,” Fauci said in an interview on Fox News.
“We really scrutinize the data very carefully to guarantee to the American public that this is a safe and efficacious vaccine,” he said.
“I think if we did any less, we would add to the already existing hesitancy on the part of many people to take the vaccine because they're concerned about safety or they're concerned that we went too quickly."
Fauci said it’s important that Americans feel good about a potential Covid-19 vaccine.
“So, it's almost a damned if you do and you're damned if you don't, because if you go quickly and you do it superficially, people are not going to want to get vaccinated,” he said.
“We have the gold standard of a regulatory approach with the FDA. The UK did not do it as carefully and they got a couple of days ahead,” he said. “I don't think that makes much difference. We'll be there. We'll be there very soon.”